{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:49:00Z","timestamp":1793317740808,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.molmed.2005.11.007","type":"journal-article","created":{"date-parts":[[2005,12,15]],"date-time":"2005-12-15T18:00:20Z","timestamp":1134669620000},"page":"17-25","source":"Crossref","is-referenced-by-count":1034,"title":["RANKL\u2013RANK signaling in osteoclastogenesis and bone disease"],"prefix":"10.1016","volume":"12","author":[{"given":"Teiji","family":"Wada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishina","family":"Hiroshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef M","family":"Penninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2005.11.007_bib1","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1146\/annurev.immunol.20.100301.064753","article-title":"RANK-L and RANK: T cells, bone loss, and mammalian evolution","volume":"20","author":"Theill","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molmed.2005.11.007_bib2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2005.11.007_bib3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1534-5807(02)00157-0","article-title":"Reaching a genetic and molecular understanding of skeletal development","volume":"2","author":"Karsenty","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1016\/j.molmed.2005.11.007_bib4","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1249\/00005768-198315050-00012","article-title":"Alterations in calcium homeostasis and bone during actual and simulated space flight","volume":"15","author":"Wronski","year":"1983","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.molmed.2005.11.007_bib5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","article-title":"A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function","volume":"390","author":"Anderson","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2005.11.007_bib6","doi-asserted-by":"crossref","first-page":"25190","DOI":"10.1074\/jbc.272.40.25190","article-title":"TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells","volume":"272","author":"Wong","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.11.007_bib7","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2005.11.007_bib8","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1210\/en.139.3.1329","article-title":"Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG\/OCIF inhibits osteoclastogenesis in vitro","volume":"139","author":"Yasuda","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmed.2005.11.007_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/bbrc.1997.6603","article-title":"Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis","volume":"234","author":"Tsuda","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2005.11.007_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2005.11.007_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0092-8674(00)00103-3","article-title":"The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development","volume":"103","author":"Fata","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2005.11.007_bib12","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1210\/en.142.4.1419","article-title":"Determination of three isoforms of the receptor activator of nuclear factor-kappaB ligand and their differential expression in bone and thymus","volume":"142","author":"Ikeda","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmed.2005.11.007_bib13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","article-title":"Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand","volume":"402","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2005.11.007_bib14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/bbrc.1999.1623","article-title":"Activated T lymphocytes support osteoclast formation in vitro","volume":"265","author":"Horwood","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2005.11.007_bib15","first-page":"49","article-title":"RANKL\/RANK\/OPG: new therapeutic targets in bone tumours and associated osteolysis","volume":"1704","author":"Wittrant","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molmed.2005.11.007_bib16","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1073\/pnas.96.7.3540","article-title":"Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand","volume":"96","author":"Hsu","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2005.11.007_bib17","doi-asserted-by":"crossref","first-page":"10905","DOI":"10.1073\/pnas.200294797","article-title":"Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene","volume":"97","author":"Kim","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2005.11.007_bib18","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","article-title":"RANK is essential for osteoclast and lymph node development","volume":"13","author":"Dougall","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2005.11.007_bib19","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","article-title":"RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism","volume":"97","author":"Li","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2005.11.007_bib20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2005.11.007_bib21","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1006\/bbrc.1998.8697","article-title":"Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor\/osteoprotegerin","volume":"247","author":"Mizuno","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2005.11.007_bib22","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2005.11.007_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/71667","article-title":"Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis","volume":"24","author":"Hughes","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2005.11.007_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJMoa013096","article-title":"Osteoprotegerin deficiency and juvenile Paget's disease","volume":"347","author":"Whyte","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2005.11.007_bib25","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/hmg\/11.18.2119","article-title":"A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype","volume":"11","author":"Cundy","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2005.11.007_bib26","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/nm960","article-title":"Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity","volume":"9","author":"Eriksson","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2005.11.007_bib27","doi-asserted-by":"crossref","first-page":"30202","DOI":"10.1074\/jbc.M403968200","article-title":"A novel in vivo role for osteoprotegerin ligand in activation of monocyte effector function and inflammatory response","volume":"279","author":"Seshasayee","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.11.007_bib28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jcb.10331","article-title":"Vitamin D and bone","volume":"88","author":"Suda","year":"2003","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.molmed.2005.11.007_bib29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1359-6101(03)00027-3","article-title":"Biology of the TRANCE axis","volume":"14","author":"Walsh","year":"2003","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.molmed.2005.11.007_bib30","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1006\/bbrc.2000.3379","article-title":"Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines","volume":"275","author":"Nakashima","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2005.11.007_bib31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ccr.2005.04.013","article-title":"MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL","volume":"7","author":"Lynch","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2005.11.007_bib32","doi-asserted-by":"crossref","first-page":"14665","DOI":"10.1074\/jbc.M010741200","article-title":"Biochemical and pharmacological criteria define two shedding activities for TRANCE\/OPGL that are distinct from the tumor necrosis factor alpha convertase","volume":"276","author":"Schlondorff","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.11.007_bib33","doi-asserted-by":"crossref","first-page":"22331","DOI":"10.1074\/jbc.M302781200","article-title":"Catalytic properties of ADAM19","volume":"278","author":"Chesneau","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.11.007_bib34","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng1294-352","article-title":"Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy","volume":"8","author":"Weber","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2005.11.007_bib35","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1101\/gad.13.8.1015","article-title":"TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling","volume":"13","author":"Lomaga","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2005.11.007_bib36","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/nm1197-1285","article-title":"Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2","volume":"3","author":"Iotsova","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2005.11.007_bib37","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1084\/jem.20042081","article-title":"I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss","volume":"201","author":"Ruocco","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2005.11.007_bib38","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/85837","article-title":"X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling","volume":"27","author":"Doffinger","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2005.11.007_bib39","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1038\/sj.onc.1207556","article-title":"Mitogen-activated protein kinases in apoptosis regulation","volume":"23","author":"Wada","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2005.11.007_bib40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/35065000","article-title":"Mammalian MAP kinase signalling cascades","volume":"410","author":"Chang","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2005.11.007_bib41","doi-asserted-by":"crossref","first-page":"31155","DOI":"10.1074\/jbc.M001229200","article-title":"Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL)","volume":"275","author":"Matsumoto","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.11.007_bib42","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1182\/blood-2004-07-2534","article-title":"Monokine induced by interferon-gamma is induced by receptor activator of nuclear factor kappa B ligand and is involved in osteoclast adhesion and migration","volume":"105","author":"Kwak","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2005.11.007_bib43","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1242\/jcs.00082","article-title":"JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms","volume":"115","author":"David","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.molmed.2005.11.007_bib44","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1359\/jbmr.2002.17.4.612","article-title":"Possible involvement of IkappaB kinase 2 and MKK7 in osteoclastogenesis induced by receptor activator of nuclear factor kappaB ligand","volume":"17","author":"Yamamoto","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2005.11.007_bib45","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1083\/jcb.200308155","article-title":"Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects","volume":"164","author":"Kenner","year":"2004","journal-title":"J. Cell Biol."},{"issue":"Suppl 2","key":"10.1016\/j.molmed.2005.11.007_bib46","doi-asserted-by":"crossref","first-page":"ii40","DOI":"10.1136\/ard.61.suppl_2.ii40","article-title":"Functions of AP1 (Fos\/Jun) in bone development","volume":"61","author":"Wagner","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.molmed.2005.11.007_bib47","doi-asserted-by":"crossref","first-page":"47366","DOI":"10.1074\/jbc.M208284200","article-title":"U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells","volume":"277","author":"Hotokezaka","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.11.007_bib48","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Takayanagi","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1016\/j.molmed.2005.11.007_bib49","doi-asserted-by":"crossref","first-page":"26475","DOI":"10.1074\/jbc.M313973200","article-title":"Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos","volume":"279","author":"Matsuo","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.11.007_bib50","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm1270","article-title":"NFAT and Osterix cooperatively regulate bone formation","volume":"11","author":"Koga","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2005.11.007_bib51","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0092-8674(91)90499-O","article-title":"Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice","volume":"64","author":"Soriano","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2005.11.007_bib52","doi-asserted-by":"crossref","first-page":"17660","DOI":"10.1074\/jbc.M311032200","article-title":"Src kinase activity is essential for osteoclast function","volume":"279","author":"Miyazaki","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.11.007_bib53","doi-asserted-by":"crossref","first-page":"31564","DOI":"10.1074\/jbc.M502703200","article-title":"Physical and functional association of c-Src and adhesion and degranulation-promoting adaptor protein (ADAP) in osteoclastogenesis in vitro","volume":"280","author":"Koga","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.11.007_bib54","doi-asserted-by":"crossref","first-page":"20551","DOI":"10.1074\/jbc.273.32.20551","article-title":"Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase","volume":"273","author":"Darnay","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.11.007_bib55","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1128\/MCB.22.4.992-1000.2002","article-title":"Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6","volume":"22","author":"Mizukami","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2005.11.007_bib56","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1073\/pnas.0500187102","article-title":"TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2\/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs","volume":"102","author":"Hauer","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2005.11.007_bib57","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1359\/JBMR.041225","article-title":"TRAF2 is essential for TNF-alpha-induced osteoclastogenesis","volume":"20","author":"Kanazawa","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2005.11.007_bib58","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1359\/jbmr.2003.18.3.443","article-title":"TRAF5 functions in both RANKL- and TNFalpha-induced osteoclastogenesis","volume":"18","author":"Kanazawa","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.molmed.2005.11.007_bib59","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nm1203","article-title":"The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis","volume":"11","author":"Wada","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2005.11.007_bib60","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1042\/0264-6021:3460561","article-title":"The PI3K-PDK1 connection: more than just a road to PKB","volume":"346","author":"Vanhaesebroeck","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.molmed.2005.11.007_bib61","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0014-5793(95)00153-Z","article-title":"Wortmannin, a specific inhibitor of phosphatidylinositol-3 kinase, blocks osteoclastic bone resorption","volume":"361","author":"Nakamura","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/j.molmed.2005.11.007_bib62","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1074\/jbc.M209299200","article-title":"PTEN regulates RANKL- and osteopontin-stimulated signal transduction during osteoclast differentiation and cell motility","volume":"278","author":"Sugatani","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.11.007_bib63","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/jmg.38.3.159","article-title":"Male breast cancer in Cowden syndrome patients with germline PTEN mutations","volume":"38","author":"Fackenthal","year":"2001","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.molmed.2005.11.007_bib64","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/nm752","article-title":"SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts","volume":"8","author":"Takeshita","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2005.11.007_bib65","doi-asserted-by":"crossref","first-page":"8286","DOI":"10.1074\/jbc.M206421200","article-title":"RANK ligand-induced elevation of cytosolic Ca2+ accelerates nuclear translocation of nuclear factor kappa B in osteoclasts","volume":"278","author":"Komarova","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.11.007_bib66","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00109-004-0612-6","article-title":"Mechanistic insight into osteoclast differentiation in osteoimmunology","volume":"83","author":"Takayanagi","year":"2005","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.molmed.2005.11.007_bib67","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1534-5807(03)00403-9","article-title":"The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis","volume":"6","author":"Duran","year":"2004","journal-title":"Dev. Cell"},{"key":"10.1016\/j.molmed.2005.11.007_bib68","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/340731","article-title":"Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1\/p62) in Paget disease of bone","volume":"70","author":"Laurin","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2005.11.007_bib69","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1172\/JCI22232","article-title":"PKClambda regulates glucose-induced insulin secretion through modulation of gene expression in pancreatic beta cells","volume":"115","author":"Hashimoto","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2005.11.007_bib70","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/35046102","article-title":"T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma","volume":"408","author":"Takayanagi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2005.11.007_bib71","doi-asserted-by":"crossref","first-page":"48251","DOI":"10.1074\/jbc.M304676200","article-title":"HIV envelope gp120-mediated regulation of osteoclastogenesis via receptor activator of nuclear factor kappa B ligand (RANKL) secretion and its modulation by certain HIV protease inhibitors through interferon-gamma\/RANKL cross-talk","volume":"278","author":"Fakruddin","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2005.11.007_bib72","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/416744a","article-title":"RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta","volume":"416","author":"Takayanagi","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2005.11.007_bib73","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.bbrc.2004.11.097","article-title":"Mechanisms of sex steroid effects on bone","volume":"328","author":"Syed","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2005.11.007_bib74","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1600-065X.1995.tb00070.x","article-title":"Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease","volume":"144","author":"Maini","year":"1995","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.molmed.2005.11.007_bib75","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJM199506083322304","article-title":"Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia","volume":"332","author":"Candeliere","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2005.11.007_bib76","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1182\/blood-2002-08-2622","article-title":"Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages","volume":"101","author":"Rahman","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2005.11.007_bib77","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.coph.2005.06.005","article-title":"Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength","volume":"5","author":"Kostenuik","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.molmed.2005.11.007_bib78","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1359\/jbmr.0301213","article-title":"Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease","volume":"19","author":"Valverde","year":"2004","journal-title":"J. Bone Miner. Res."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491405002674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491405002674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T14:51:06Z","timestamp":1547909466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491405002674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S1471491405002674"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2005.11.007","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}